stefano piaserico

About stefano piaserico

stefano piaserico, With an exceptional h-index of 44 and a recent h-index of 34 (since 2020), a distinguished researcher at Università degli Studi di Padova, specializes in the field of dermatology, skin cancer, psoriasis, photodermatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Ablative CO2-Assisted Laser for Topical Drug Delivery in Nail Psoriasis: A Systematic Review

Epidemiology, characteristics of disease and unmet needs of patients with generalized pustular psoriasis: a large Italian Delphi consensus.

Cardiovascular Magnetic Resonance in Psoriasis Patient for Diagnosing Myocarditis and Guiding the Biologic Therapy

Deucravacitinib: is there still a place or a need for a new oral agent?

Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series

Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe …

Commentary: unmet needs in generalized pustular psoriasis in clinical practice

Coronary Microvascular Dysfunction in Asymptomatic Patients with Severe Psoriasis

stefano piaserico Information

University

Position

___

Citations(all)

7041

Citations(since 2020)

3939

Cited By

4408

hIndex(all)

44

hIndex(since 2020)

34

i10Index(all)

122

i10Index(since 2020)

95

Email

University Profile Page

Google Scholar

stefano piaserico Skills & Research Interests

dermatology

skin cancer

psoriasis

photodermatology

Top articles of stefano piaserico

Ablative CO2-Assisted Laser for Topical Drug Delivery in Nail Psoriasis: A Systematic Review

2024/4/2

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Epidemiology, characteristics of disease and unmet needs of patients with generalized pustular psoriasis: a large Italian Delphi consensus.

Dermatology (Basel, Switzerland)

2024/3/17

Cardiovascular Magnetic Resonance in Psoriasis Patient for Diagnosing Myocarditis and Guiding the Biologic Therapy

Journal of Cardiovascular Magnetic Resonance

2024/3/1

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Alessia Pepe
Alessia Pepe

H-Index: 10

Deucravacitinib: is there still a place or a need for a new oral agent?

British Journal of Dermatology

2024/2/26

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Kaposi’s Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series

Cancers

2024/2/6

Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe …

Journal of the American Academy of Dermatology

2024/2/1

Commentary: unmet needs in generalized pustular psoriasis in clinical practice

Dermatology and Therapy

2024/1

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Paolo Gisondi
Paolo Gisondi

H-Index: 41

Coronary Microvascular Dysfunction in Asymptomatic Patients with Severe Psoriasis

Journal of Investigative Dermatology

2023/10/1

Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients

Journal of the European Academy of Dermatology and Venereology: JEADV

2023/10

43878 Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial

Journal of the American Academy of Dermatology

2023/9/1

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Brian Kirby
Brian Kirby

H-Index: 18

Real-world experience of methotrexate in the treatment of skin diseases: an Italian Delphi Consensus

Dermatology and Therapy

2023/6

Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104‐week multicenter retrospective study–IL PSO …

Journal of the European Academy of Dermatology and Venereology

2023/5

Long‐term stability of PASI< 3 response to tildrakizumab: Pooled analyses from reSURFACE 1 and reSURFACE 2 phase 3 trials through 5 years

Journal of the European Academy of Dermatology and Venereology

2023/4

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study

Vaccines

2023/3/27

Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of …

Frontiers in Medicine

2023

Stefano Piaserico
Stefano Piaserico

H-Index: 26

The transition from mild to moderate-to-severe chronic plaque psoriasis

Journal of the European Academy of Dermatology and Venereology

2023

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study

Acta Dermato-Venereologica

2023

Paolo Gisondi
Paolo Gisondi

H-Index: 41

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Painless Plaques Evolving to Bullae and Painful Erosions on the Penis: A Quiz

Acta Dermato-Venereologica

2023

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Treatment of psoriasis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations

2023/1/1

Paolo Gisondi
Paolo Gisondi

H-Index: 41

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity

Diabetes, Metabolic Syndrome and Obesity

2023/12/31

Stefano Piaserico
Stefano Piaserico

H-Index: 26

Vincenzo Vindigni
Vincenzo Vindigni

H-Index: 27

See List of Professors in stefano piaserico University(Università degli Studi di Padova)